(Q50850914)

24 March 2018

title

Sex hormone binding globulin and free levonorgestrel index in the first week after insertion of Norplant implants. (English)

1 reference

24 March 2018

levonorgestrel-releasing implant

main subject

1 reference

1 reference

F Alvarez

1

1 reference

24 March 2018

V Brache

2

1 reference

24 March 2018

A S Tejada

3

1 reference

24 March 2018

L Cochon

4

1 reference

24 March 2018

A Faundes

5

1 reference

24 March 2018

publication date

1 October 1998

1 reference

24 March 2018

published in

Contraception

1 reference

24 March 2018

volume

58

1 reference

24 March 2018

issue

4

1 reference

24 March 2018

page(s)

211-214

1 reference

24 March 2018

The interaction between sex hormone binding globulin and levonorgestrel released from vaginal rings in women

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900102-4

Ovarian function during use of a levonorgestrel-releasing IUD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900102-4

Pharmacokinetics of levonorgestrel in 12 women who received a single oral dose of 0.15 mg levonorgestrel and, after a washout phase, the same dose during one treatment cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900102-4

Serum SHBG levels during normal menstrual cycle and after insertion of levonorgestrel-releasing IUD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900102-4

Pharmacokinetic and pharmacodynamic effects of vaginal rings releasing levonorgestrel at a rate of 27 micrograms/24 hours: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900102-4

The interaction between sex hormone binding globulin and levonorgestrel released from Norplant, an implantable contraceptive

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900102-4

Changes in serum levels of SHBG, endogenous ligands and levonorgestrel induced by ethinylestradiol in Norplant users

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900102-4

Free levonorgestrel index and its relationship with luteal activity during long-term use of Norplant implants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900102-4

Plasma levels of levonorgestrel and free levonorgestrel index in women using NORPLANT implants or two covered rods (NORPLANT-2)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900102-4

Steroid release from silastic capsules and rods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900102-4

Plasma levels of d-norgestrel, estradiol and progesterone during treatment with silastic implants containing d-norgestrel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900102-4

First week drug concentrations in women with levonorgestrel rod or Norplant capsule implants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900102-4

Plasma levels of d-norgestrel after oral administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900102-4

10.1016/S0010-7824(98)00102-4

7 January 2021

Identifiers

DOI

1 reference

24 March 2018

1 reference

24 March 2018